Adalimumab for Induction of Histological Remission in Moderately to Severely Active Ulcerative Colitis
出版年份 2018 全文链接
标题
Adalimumab for Induction of Histological Remission in Moderately to Severely Active Ulcerative Colitis
作者
关键词
Ulcerative colitis, Adalimumab, Histological remission, Mucosal healing, GEBOES Index, Tumor necrosis factor antagonists
出版物
DIGESTIVE DISEASES AND SCIENCES
Volume 63, Issue 3, Pages 731-737
出版商
Springer Nature
发表日期
2018-01-25
DOI
10.1007/s10620-018-4935-5
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Histology Grade Is Independently Associated With Relapse Risk in Patients With Ulcerative Colitis in Clinical Remission: A Prospective Study
- (2016) Talia Zenlea et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Adalimumab Maintenance Treatment in Ulcerative Colitis: Outcomes by Prior Anti-TNF Use and Efficacy of Dose Escalation
- (2016) Carlos Taxonera et al. DIGESTIVE DISEASES AND SCIENCES
- Endoscopic Mucosal Healing Predicts Favorable Clinical Outcomes in Inflammatory Bowel Disease
- (2016) Andrew R. Reinink et al. INFLAMMATORY BOWEL DISEASES
- Higher Adalimumab Levels Are Associated with Histologic and Endoscopic Remission in Patients with Crohnʼs Disease and Ulcerative Colitis
- (2016) Andres J. Yarur et al. INFLAMMATORY BOWEL DISEASES
- Are Anti-Tumor Necrosis Factor Trough Levels Predictive of Mucosal Healing in Patients With Inflammatory Bowel Disease?
- (2016) Edward L. Barnes et al. JOURNAL OF CLINICAL GASTROENTEROLOGY
- Histological Outcomes and Predictive Value of Faecal Markers in Moderately to Severely Active Ulcerative Colitis Patients Receiving Infliximab
- (2016) Fernando Magro et al. Journal of Crohns & Colitis
- Effectiveness of adalimumab for the treatment of ulcerative colitis in clinical practice: comparison between anti-tumour necrosis factor-naïve and non-naïve patients
- (2016) Marisa Iborra et al. JOURNAL OF GASTROENTEROLOGY
- Review article: the histological assessment of disease activity in ulcerative colitis
- (2015) A. Marchal Bressenot et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE): Determining Therapeutic Goals for Treat-to-Target
- (2015) L Peyrin-Biroulet et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Beyond endoscopic mucosal healing in UC: histological remission better predicts corticosteroid use and hospitalisation over 6 years of follow-up
- (2015) Robert V Bryant et al. GUT
- Efficacy and Safety of Adalimumab in Ulcerative Colitis Refractory to Conventional Therapy in Routine Clinical Practice
- (2015) Anita Bálint et al. Journal of Crohns & Colitis
- Evaluation of the Risk of Relapse in Ulcerative Colitis According to the Degree of Mucosal Healing (Mayo 0 vs 1): A Longitudinal Cohort Study
- (2015) Manuel Barreiro-de Acosta et al. Journal of Crohns & Colitis
- Histological healing after infliximab induction therapy in children with ulcerative colitis
- (2015) Anna Wiernicka WORLD JOURNAL OF GASTROENTEROLOGY
- Four-Year Maintenance Treatment With Adalimumab in Patients with Moderately to Severely Active Ulcerative Colitis: Data from ULTRA 1, 2 and 3
- (2014) Jean-Frederic Colombel et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Histological healing favors lower risk of colon carcinoma in extensive ulcerative colitis
- (2014) Burton I Korelitz WORLD JOURNAL OF GASTROENTEROLOGY
- Impact of mucosal healing on long-term outcomes in ulcerative colitis treated with infliximab: a multicenter experience
- (2013) D. Laharie et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Histologic Markers of Inflammation in Patients With Ulcerative Colitis in Clinical Remission
- (2013) Laura Rosenberg et al. Clinical Gastroenterology and Hepatology
- Adalimumab in active ulcerative colitis: A “real-life” observational study
- (2013) Alessandro Armuzzi et al. DIGESTIVE AND LIVER DISEASE
- Subcutaneous Golimumab Maintains Clinical Response in Patients With Moderate-to-Severe Ulcerative Colitis
- (2013) William J. Sandborn et al. GASTROENTEROLOGY
- Predictors of Endoscopic Inflammation in Patients With Ulcerative Colitis in Clinical Remission
- (2013) Laura Rosenberg et al. INFLAMMATORY BOWEL DISEASES
- Correlation Between the Endoscopic and Histologic Score in Assessing the Activity of Ulcerative Colitis
- (2013) Bart Lemmens et al. INFLAMMATORY BOWEL DISEASES
- Prognostic Value of Serologic and Histologic Markers on Clinical Relapse in Ulcerative Colitis Patients With Mucosal Healing
- (2012) Talat Bessissow et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Mucosal healing restores normal health and quality of life in patients with inflammatory bowel disease
- (2012) Francesc Casellas et al. EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY
- Achievement of deep remission during scheduled maintenance therapy with TNFα-blocking agents in IBD
- (2012) Pauliina Molander et al. Journal of Crohns & Colitis
- Observational study on the efficacy of adalimumab for the treatment of ulcerative colitis and predictors of outcome
- (2012) Orlando García-Bosch et al. Journal of Crohns & Colitis
- Severity of Inflammation as a Predictor of Colectomy in Patients With Chronic Ulcerative Colitis
- (2011) Marco M. Hefti et al. DISEASES OF THE COLON & RECTUM
- Early Mucosal Healing With Infliximab Is Associated With Improved Long-term Clinical Outcomes in Ulcerative Colitis
- (2011) Jean Frédéric Colombel et al. GASTROENTEROLOGY
- Adalimumab Induces and Maintains Clinical Remission in Patients With Moderate-to-Severe Ulcerative Colitis
- (2011) William J. Sandborn et al. GASTROENTEROLOGY
- Majority of patients with inflammatory bowel disease in clinical remission have mucosal inflammation
- (2011) Judith E. Baars et al. INFLAMMATORY BOWEL DISEASES
- Clinical trial: controlled, open, randomized multicentre study comparing the effects of treatment on quality of life, safety and efficacy of budesonide or mesalazine enemas in active left-sided ulcerative colitis
- (2010) F. Hartmann et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Importance of mucosal healing in ulcerative colitis
- (2009) Gary R. Lichtenstein et al. INFLAMMATORY BOWEL DISEASES
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More